Upcoming TB Events and Webinars for Healthcare Professionals
Various upcoming tuberculosis (TB) events and webinars targeted at healthcare professionals, covering topics such as diabetes and TB, TB drug-resistant regimens, and culturally responsive TB education. Includes details on dates, times, and registration information. Stay informed and engage with experts in the field to enhance your knowledge and skills in managing TB cases effectively.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
TB Nurse Network 10/20/21 Call in Option: 1-248-509-0316 Pin: 720-385-245# *Please remember to mute yourself
Dr. Sunstrum Webinars TB Seminars hosted by Dr. Sunstrum have resumed Held the third Friday of each month from 8:15 to 9:30 am Next one: 11/19/21 Click here to join the meeting
Heartland National TB Center Trainings Diabetes and TB 11/18/21 from 1:00 to 2:15 pm Objective: discuss the impact of diabetes on the diagnosis, management, and treatment of the patient with TB. Register here: Diabetes and Tuberculosis - The Real Story (constantcontact.com)
TB Expert Network: Unplugged 12/10/21 1:30 to 3 pm Rescheduled from 11/19/21 Hosted by Curry International TB Center Forum to discuss challenging or complicated TB cases with other TB experts
COVID-19 & TB Recording of the webcast: COVID-19/TB Diagnostic Delays and Unrecognized Risk for Progression of LTBI to TB Disease Webinar hosted by Heartland National TB Center and National TB Nurse s Coalition
New England TB Clinicians Conference 10/27 from 1:00 to 4:30 pm Hosted by Rutgers Global TB Institute Topics will include: What s New in TB Drug-Resistant TB Regimens Refocusing on LTBI TB Case Discussions Register here: New England TB Clinicians Conference (constantcontact.com)
TB ETN Webinar Series: Culturally Responsive TB Education and Training Part 1: November 4 from 2:30 to 4 pm Part 2: November 18 from 2:30 to 4 pm Designed for health educators or others who develop TB education and training New publication available: Questions and Answers About Tuberculosis Download or order print copies for free Available in English, Spanish, Vietnamese, Tagalog, Dari, & Pashto
World TB Day We are planning a World TB Day event for 2022! Will be held in March of next year Hybrid event with both in-person and online options for attendance
Updated CDC Recommendations NEW CDC RECOMMENDATION: TST or IGRA tests for TB can be done before, after, or during the same encounter as a COVID-19 vaccination COVID vaccination should not be delayed because of TB testing Previous recommendation: Wait at least four weeks after COVID-19 vaccination to perform a TST or IGRA Recommendation has been updated because of issues with delaying TB testing
Trial of Four-Month TB Treatment Regimens Published May 6, 2021, New England Journal of Medicine. DOI: 10.1056/NEJMoa2033400. Big Picture: Would a 4-month treatment regimen using Rifapentine and/or Moxifloxacin give outcomes *at least as good* as the current standard 6-month regimen? Noninferiority Trial. Noninferior = *not worse than* the standard or control regimen. All data and figures are from the NEJM article and/or accompanying Research Summary, or from a webinar as noted. * = Peter s own words.
From webinar 9/21/2021. TB Centers of Excellence & CDC. S Dorman, P Nahid, P Phillips, R Chaisson, E Kurbatova.
From webinar 9/21/2021. TB Centers of Excellence & CDC. S Dorman, P Nahid, P Phillips, R Chaisson, E Kurbatova.
Efficacy Results Percent of population with TB disease. Cut-point for Noninferiority: Left is better. Rifapentine confidence interval crosses cut-point: Rifapentine was Inferior to Control.
Safety Results Incidence of adverse events similar between Rifapentine- Moxifloxacin and Control.
*Summary* 4-month treatment containing Rifapentine & Moxifloxacin was Noninferior compared to standard 6-month regimen. 4-month containing Rifapentine was Inferior. Remember this was a Trial, not Recommendations. No recommendations for or against using the Rifapentine-Moxifloxacin regimen. Considerations. Rapid drug-susceptibility testing for: Fluoroquinolones, Isoniazid, Rifampin. E.g., CDC s Molecular Detection of Drug Resistance (MDDR). Rifapentine is absorbed better with high-fat foods. Rifapentine/Moxifloxacin regimen may cost more per-dose than standard regimen. Will fewer total doses offset higher per-dose cost?
TST Workshop If you have questions about the TST workshop, please use the MDHHS-TSTworkshop@michigan.gov email Online TST workshop is in progress We have faced technical issues and have no estimated date of completion at this time Once workshop is ready, we will notify the group Even once online version is up and running, an in-person practicum will still need to be completed for each participant
Open Forum Any thoughts, questions, or items for discussion?
Thanks! Meeting resources will be sent to everyone on the TB Nurse Network listserv and posted on our website Next meeting will be January 19, 2022 Website will be updated to show all 2022 TBNN meeting dates Contact Claire Berlin at berlinc@michigan.gov with any questions, suggested topics, or comments
